Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Two different dosing regimens demonstrated efficacy with one showing a better profile
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
The EnSite X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures
Join us Wednesday, November 18, to discover the impact metal interactions have on oligo analysis
Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine
This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings
The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution
To expand Minimally Invasive Surgery field by reinforcing its orthopedics business
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
Which new products made the most difference to your lab work this year?
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
